Wildlife Health Market Report 2025

The wildlife health market size has grown rapidly in recent years. It will grow from $2.49 billion in 2024 to $2.75 billion in 2025 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to habitat destruction, availability of wildlife veterinary care facilities, advanced technologies in delivering medicines for animals in sanctuaries/zoos, increasing government initiatives to prevent zoonotic diseases from wild reservoirs.

The wildlife health market size is expected to see rapid growth in the next few years. It will grow to $4.08 billion in 2029 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to surging demand for various animal health products, regional prospects, growing demand for companion animal health products, strategic moves by industry leaders, increasing demand for veterinary software. Major trends in the forecast period include global collaboration in disease surveillance, data analytics and artificial intelligence, growing number of wildlife conservation measures, programs and funding activities.

The rise in the incidence of zoonotic diseases is expected to drive the growth of the wildlife health market in the future. A zoonotic disease refers to any illness or infection that can be transmitted between animals and humans. The increase in zoonotic diseases will support the advancement and development of various health-related products for wildlife health. For example, in December 2023, the European Food Safety Authority (EFSA), an Italy-based government agency, reported that in 2022, campylobacteriosis and salmonellosis were the two most commonly reported zoonoses in humans, with 137,107 and 65,208 cases, respectively. Campylobacteriosis experienced a slight decline of 210 cases, while salmonellosis saw an increase of 5,039 cases. Nevertheless, the incidence rates per 100,000 inhabitants remained stable at 43.1 for campylobacteriosis and 15.3 for salmonellosis, in line with 2021 levels. Thus, the rise in zoonotic disease incidence is propelling the growth of the wildlife health market.

The growth of the wildlife health market is also anticipated to be fueled by wildlife conservation measures and funding activities. Wildlife conservation involves a range of strategies aimed at preserving biodiversity, requiring substantial funding for habitat restoration, anti-poaching efforts, research initiatives, and community engagement. The wildlife health market plays a crucial role in supporting these efforts by providing essential services, diagnostics, and treatments that contribute to the overall well-being of wildlife populations. For instance, in September 2023, the United States Department of the Interior allocated over $40.6 million in grants to 10 states and the U.S. through the U.S. Fish and Wildlife Service, supporting habitat acquisition and protection. Therefore, wildlife conservation measures and funding activities are driving the growth of the wildlife health market.

Technological advancements are a significant trend gaining traction in the wildlife health market. Major companies within this market are embracing new technologies to maintain their competitive edge. For example, in February 2023, the U.S. Department of Agriculture (USDA), a federal agency in the U.S., introduced new tests to track and detect COVID variants in both wild and domestic animals. These tools assist in managing the spread of zoonotic diseases. The USDA Animal and Plant Health Inspection Service (APHIS) is implementing a $300 million provision from the American Rescue Plan Act to monitor and surveil susceptible animals for the COVID virus. Through this initiative, the Agricultural Research Service (ARS), in collaboration with APHIS, is conducting five research projects to enhance understanding of the virus and help APHIS achieve its goal of establishing an early warning system to potentially prevent or mitigate future zoonotic disease outbreaks or global pandemics.

Strategic partnerships are a notable approach adopted by major companies in the wildlife health market to enhance pathogen control in equine environments. Strategic partnerships involve companies leveraging each other's strengths and resources for mutual benefits. In May 2023, the United States Equestrian Federation partnered with Merck Animal Health and ByoPlanet to integrate ByoPlanet's advanced technology with Merck Animal Health's antimicrobial solutions. This collaboration offers a comprehensive approach to enhancing pathogen control in equine environments, addressing wildlife health challenges proactively and introducing innovative products to positively impact the broader wildlife health market, particularly in the equine sector.

In June 2022, Zoetis Inc., a U.S.-based pharmaceutical company, acquired Basepaws for an undisclosed amount. The acquisition of Basepaws is expected to strengthen Zoetis Inc.'s presence in the precision animal health sector and guide future advancements in pet care. Basepaws, a U.S.-based company, specializes in offering DNA tests for cats and dogs.

Major companies operating in the wildlife health market include Bayer AG, Novartis AG, Merck & Co Inc., Boehringer Ingelheim International GmbH, Elanco Animal Health Incorporated, IDEXX Laboratories Inc., Génia USA Inc., Orion Corporation, Virbac Group, Royal Canin, Ceva Santé Animale Group, Phibro Animal Health Corporation, Dechra Pharmaceuticals PLC, Huvepharma, Vétoquinol, Indian Immunologicals Limited, Norbrook Laboratories Limited, Heska Corporation, Biogenesis Bago, Animalcare Group plc, Pneu-Dart Inc., PetAg Inc.

North America was the largest region in the wildlife health market in 2024. The regions covered in the wildlife health market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the wildlife health market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Wildlife health encompasses the physical, behavioral, and social well-being of an animal, considering its individual, population, and broader ecosystem levels, along with its capacity to adapt to change. It involves addressing the diverse stressors affecting wildlife.

The primary categories of wildlife health include mammals, birds, fish, reptiles, and amphibians. Mammals denote members of the vertebrate animal family whose offspring are nourished by the mother's milk from specific mammary glands. The products comprise medicine, equipment, and consumables, utilizing various routes of administration such as oral, injectable, and others. The end users encompass zoos, wildlife sanctuaries, wildlife rescue and rehabilitation centers, among others.

The wildlife health market research report is one of a series of new reports that provides wildlife health market statistics, including wildlife health industry global market size, regional shares, competitors with a wildlife health market share, detailed wildlife health market segments, market trends and opportunities, and any further data you may need to thrive in the wildlife health industry. This wildlife health market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The wildlife health market consists of sales of immobilizing drugs, pharmaceutical drugs, and vaccines. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.